BioStem Technologies (OTCMKTS:BSEM) Issues Earnings Results

BioStem Technologies (OTCMKTS:BSEMGet Free Report) released its quarterly earnings data on Monday. The company reported -0.14 earnings per share for the quarter, reports. The business had revenue of 11.44 million during the quarter, compared to analyst estimates of 11.40 million.

BioStem Technologies Trading Down 5.3 %

Shares of OTCMKTS BSEM traded down 0.74 during mid-day trading on Thursday, hitting 13.15. The company had a trading volume of 21,800 shares, compared to its average volume of 28,903. BioStem Technologies has a 1-year low of 1.20 and a 1-year high of 15.50. The business’s 50-day moving average price is 8.86.

BioStem Technologies Company Profile

(Get Free Report)

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

Read More

Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.